ProQR Therapeutics NV operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares ProQR Therapeutics NV with three other
companies in this sector in UNITED STATES :
Global Blood Therapeutics Inc
(2019
sales of $2.11 million
of which 100%
was Pharmaceutical),
Synlogic Inc
($2.22 million
of which 100%
was Discovery and development of synthetic b), and
Clearside Biomedical Inc
($2.17 million
of which 100%
was Pharmaceutical).
Sales Analysis.
Sales fell dramatically in 2019:
ProQR Therapeutics NV reported sales of $2.16 million
for the
year ending
December of 2019.
This
represents
a
sharp
decrease of 68.2%
versus 2018, when the company's sales were $6.79 million.